Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Prepaid Assets (2020 - 2025)

Mirum Pharmaceuticals has reported Prepaid Assets over the past 6 years, most recently at $18.1 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $18.1 million for Q4 2025, up 53.94% from a year ago — trailing twelve months through Dec 2025 was $18.1 million (up 53.94% YoY), and the annual figure for FY2025 was $18.1 million, up 53.94%.
  • Prepaid Assets for Q4 2025 was $18.1 million at Mirum Pharmaceuticals, down from $23.9 million in the prior quarter.
  • Over the last five years, Prepaid Assets for MIRM hit a ceiling of $23.9 million in Q3 2025 and a floor of $3.8 million in Q2 2022.
  • Median Prepaid Assets over the past 5 years was $9.4 million (2023), compared with a mean of $10.3 million.
  • Biggest five-year swings in Prepaid Assets: fell 16.32% in 2022 and later surged 157.52% in 2023.
  • Mirum Pharmaceuticals' Prepaid Assets stood at $5.3 million in 2021, then surged by 69.74% to $8.9 million in 2022, then grew by 22.22% to $10.9 million in 2023, then grew by 7.76% to $11.8 million in 2024, then skyrocketed by 53.94% to $18.1 million in 2025.
  • The last three reported values for Prepaid Assets were $18.1 million (Q4 2025), $23.9 million (Q3 2025), and $19.1 million (Q2 2025) per Business Quant data.